173 related articles for article (PubMed ID: 37358604)
1. Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI: a multicenter and multireader study.
El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
Abdom Radiol (NY); 2023 Oct; 48(10):3039-3049. PubMed ID: 37358604
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MRI response evaluation methods in rectal cancer: a multicentre and multireader validation study.
El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
Eur Radiol; 2023 Jun; 33(6):4367-4377. PubMed ID: 36576549
[TBL] [Abstract][Full Text] [Related]
3. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.
van Griethuysen JJM; Lambregts DMJ; Trebeschi S; Lahaye MJ; Bakers FCH; Vliegen RFA; Beets GL; Aerts HJWL; Beets-Tan RGH
Abdom Radiol (NY); 2020 Mar; 45(3):632-643. PubMed ID: 31734709
[TBL] [Abstract][Full Text] [Related]
4. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
[TBL] [Abstract][Full Text] [Related]
5. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
Lee HJ; Chung WS; An JH; Kim JH
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.
Lee ES; Kim MJ; Park SC; Hur BY; Hyun JH; Chang HJ; Baek JY; Kim SY; Kim DY; Oh JH
Eur Radiol; 2018 Feb; 28(2):496-505. PubMed ID: 28786006
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
[TBL] [Abstract][Full Text] [Related]
8. Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer.
Guner OS; Tumay LV
Asian J Surg; 2021 Jun; 44(6):841-847. PubMed ID: 33573925
[TBL] [Abstract][Full Text] [Related]
9. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?
Maizlin ZV; Brown JA; So G; Brown C; Phang TP; Walker ML; Kirby JM; Vora P; Tiwari P
Dis Colon Rectum; 2010 Mar; 53(3):308-14. PubMed ID: 20173478
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
11. Sense and nonsense of yT-staging on MRI after chemoradiotherapy in rectal cancer.
El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
Colorectal Dis; 2023 Sep; 25(9):1878-1887. PubMed ID: 37545140
[TBL] [Abstract][Full Text] [Related]
12. Selection of Patients With Rectal Cancer for Preoperative Chemoradiotherapy: Are T Category and Nodal Status All That Matters?
Pooni A; Al-Sukhni E; Milot L; Fruitman M; Victor JC; Schmocker S; Brown G; Kennedy E
Dis Colon Rectum; 2019 Apr; 62(4):447-453. PubMed ID: 30451758
[TBL] [Abstract][Full Text] [Related]
13. Primary and post-chemoradiotherapy MRI detection of extramural venous invasion in rectal cancer: the role of diffusion-weighted imaging.
Fornell-Perez R; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Porcel-de-Peralta G; Loro-Ferrer JF
Radiol Med; 2020 Jun; 125(6):522-530. PubMed ID: 32020526
[TBL] [Abstract][Full Text] [Related]
14. Pearls and pitfalls of structured staging and reporting of rectal cancer on MRI: an international multireader study.
El Khababi N; Beets-Tan RG; Curvo-Semedo L; Tissier R; Nederend J; Lahaye MJ; Maas M; Beets GL; Lambregts DM;
Br J Radiol; 2023 Oct; 96(1150):. PubMed ID: 38696592
[TBL] [Abstract][Full Text] [Related]
15. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival.
Zhang XY; Wang S; Li XT; Wang YP; Shi YJ; Wang L; Wu AW; Sun YS
Radiology; 2018 Dec; 289(3):677-685. PubMed ID: 30152742
[TBL] [Abstract][Full Text] [Related]
16. MRI Detection of Extramural Venous Invasion in Rectal Cancer: Correlation With Histopathology Using Elastin Stain.
Jhaveri KS; Hosseini-Nik H; Thipphavong S; Assarzadegan N; Menezes RJ; Kennedy ED; Kirsch R
AJR Am J Roentgenol; 2016 Apr; 206(4):747-55. PubMed ID: 26933769
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multiparametric MRI scoring system for histopathologic treatment response following preoperative chemoradiotherapy for rectal cancer.
Khwaja SA; Thipphavong S; Kirsch R; Menezes RJ; Kennedy ED; Brierley JD; Jhaveri KS
Eur J Radiol; 2021 May; 138():109628. PubMed ID: 33721764
[TBL] [Abstract][Full Text] [Related]
18. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
19. Evaluation of the Extent of Mesorectal Invasion and Mesorectal Fascia Involvement in Patients with T3 Rectal Cancer With 2-D and 3-D Transrectal Ultrasound: A Pilot Comparison Study With Magnetic Resonance Imaging Findings.
Liu M; Yin S; Li Q; Liu Y; Pei X; Han F; Li AH; Zhou J
Ultrasound Med Biol; 2020 Nov; 46(11):3008-3016. PubMed ID: 32868155
[TBL] [Abstract][Full Text] [Related]
20. Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: Development and validation of a classification algorithm.
Rengo M; Landolfi F; Picchia S; Bellini D; Losquadro C; Badia S; Caruso D; Iannicelli E; Osti MF; Tombolini V; Carbone I; Giunta G; Laghi A
Eur J Radiol; 2022 Feb; 147():110146. PubMed ID: 34998098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
